BATF2 and tuberculosis: These were Kaforou25 (86·9% [80·9–92·9]), Roe3 (86·9% [80·3–93·5]), and BATF2 (86·8% [80·6–93·1]; appendix 1, p 9) all derived from individual case-control studies comparing patients with tuberculosis with healthy controls.13, 27, 31 The remaining 23 signatures had inferior AUROCs.